Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Epilepsy and Seizures: Overview

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Epilepsy ll: Types

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.

Seizures l: Introduction

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...

Seizures: Classification

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Preclinical Evidence for a Drug-Drug Interaction Between Cannabinol and Melatonin.

Basic & clinical pharmacology & toxicology·2024

Same author

A high seizure burden increases brain concentrations of specialized pro-resolving mediators in the Scn1a<sup>+/-</sup> mouse model of Dravet syndrome.

Prostaglandins & other lipid mediators·2024

Same author

Novel mouse model of alternating hemiplegia of childhood exhibits prominent motor and seizure phenotypes.

Neurobiology of disease·2024

Same author

Brain on Fire: How Brain Infection and Neuroinflammation Drive Worldwide Epilepsy Burden.

Epilepsy currents·2024

Same author

Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8.

Mammalian genome : official journal of the International Mammalian Genome Society·2024

Same author

Fine Mapping and Candidate Gene Analysis of Dravet Syndrome Modifier Loci on Mouse Chromosomes 7 and 8.

bioRxiv : the preprint server for biology·2024

Search research articles

Related Experiment Video

Updated: May 19, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Advances in epilepsy genetics and genomics.

Jennifer A Kearney¹

¹Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.

Epilepsy Currents

|September 1, 2012

Summary

High-throughput genomic analysis is revolutionizing genetic mutation identification. Applying these advanced technologies to epilepsy research will deepen our understanding of its genetic basis and uncover new treatments.

Area of Science:

Genetics and genomics
Neurology
Biotechnology

Background:

Genomic technologies are rapidly advancing mutation identification.
Understanding the genetic basis of epilepsy is crucial for developing effective treatments.
High-throughput genomic analysis offers powerful tools for genetic research.

Purpose of the Study:

To explore the application of current and emerging mutation identification technologies in epilepsy research.
To accelerate the discovery of genetic factors contributing to common epilepsy forms.
To identify novel therapeutic strategies for epilepsy treatment based on genetic findings.

Main Methods:

Utilizing high-throughput genomic analysis techniques.
Applying advanced genetic sequencing and analysis platforms.

More Related Videos

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy

Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy

Published on: October 19, 2021

Related Experiment Videos

Last Updated: May 19, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy

Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy

Published on: October 19, 2021

Integrating genomic data with clinical epilepsy information.

Main Results:

Emerging technologies are significantly enhancing the pace of genetic discovery.
Genomic analysis is poised to reveal the genetic underpinnings of common epilepsy types.
New insights into epilepsy genetics can guide the development of targeted therapies.

Conclusions:

The integration of advanced genomic technologies in epilepsy research is transformative.
This approach will significantly improve our comprehension of epilepsy's genetic etiology.
Novel therapeutic avenues for epilepsy are expected to emerge from these genetic discoveries.